Published in Clin Infect Dis on December 15, 2015
Trichomonas Vaginalis Repeat Infections Among HIV Negative Women | NCT01832480
Morphologic study of the effect of iron on pseudocyst formation in Trichomonas vaginalis and its interaction with human epithelial cells. Mem Inst Oswaldo Cruz (2017) 0.75
Therapeutic effects of Iranian herbal extracts against Trichomonas vaginalis Iran Biomed J (2017) 0.75
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis (1997) 6.64
Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis (2013) 5.40
Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis (2007) 4.12
Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis (2008) 3.98
The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol (2008) 3.60
The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis (2007) 3.42
Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis (2006) 3.17
Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis (2012) 3.06
Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis (2007) 2.85
Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J Infect Dis (2005) 2.55
Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. J Natl Cancer Inst (2009) 2.50
Demographic, behavioral, and clinical characteristics of men with nongonococcal urethritis differ by etiology: a case-comparison study. Sex Transm Dis (2011) 2.41
The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis (2013) 2.39
The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis (2005) 2.31
Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis (2009) 2.30
Characteristics of three vaginal flora patterns assessed by gram stain among pregnant women. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1992) 2.27
The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women. Sex Transm Infect (2011) 2.19
Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis (2002) 2.14
Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2006) 2.00
A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol (2007) 1.93
Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. Clin Infect Dis (2011) 1.92
Rates of and risk factors for trichomoniasis among pregnant inmates in New York City. Sex Transm Dis (1998) 1.92
Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am J Obstet Gynecol (2009) 1.87
Prevention of sexually transmitted infections in urban communities (Peru PREVEN): a multicomponent community-randomised controlled trial. Lancet (2012) 1.80
Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex Transm Infect (2003) 1.72
Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol (2012) 1.68
Risk factors of HIV vertical transmission in a cohort of women under a PMTCT program at three peri-urban clinics in a resource-poor setting. J Perinatol (2010) 1.64
A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women. Sex Transm Dis (2010) 1.61
Male circumcision and Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention. Sex Transm Infect (2008) 1.58
Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection. J Infect Dis (2013) 1.56
Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial. Int J Cancer (2009) 1.56
Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial. J Clin Microbiol (2011) 1.56
High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med (2006) 1.56
Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J Clin Microbiol (2006) 1.55
Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex Transm Dis (2003) 1.52
Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard. Obstet Gynecol (2009) 1.46
Trichomoniasis and other sexually transmitted infections: results from the 2001-2004 National Health and Nutrition Examination Surveys. Sex Transm Dis (2009) 1.45
Paromomycin treatment of recalcitrant Trichomonas vaginalis. Int J STD AIDS (2010) 1.43
Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses. Br J Vener Dis (1975) 1.41
Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States. Sex Transm Dis (2004) 1.41
The HPTN 024 Study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth. Am J Obstet Gynecol (2006) 1.37
Trichomoniasis and HIV interactions: a review. Sex Transm Infect (2013) 1.36
Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother (2006) 1.36
High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J Infect Dis (2003) 1.35
The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis (2006) 1.35
Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection. Clin Infect Dis (2002) 1.35
Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implications. J Clin Microbiol (2011) 1.34
Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis (2010) 1.29
Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial. Sex Transm Dis (2006) 1.26
In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrob Agents Chemother (2003) 1.25
Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Sex Transm Dis (2010) 1.25
Persistent, undetected Trichomonas vaginalis infections? Clin Infect Dis (2009) 1.25
Ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: implications for prevention interventions. Sex Transm Dis (2012) 1.23
Trichomonas vaginalis genital infections: progress and challenges. Clin Infect Dis (2011) 1.22
Trichomonas vaginalis infection in women who submit self-obtained vaginal samples after internet recruitment. Sex Transm Dis (2011) 1.21
Factors associated with the prevalence and incidence of Trichomonas vaginalis infection among African American women in New York city who use drugs. J Infect Dis (2008) 1.20
Aetiology of urethral discharge in Bangui, Central African Republic. Sex Transm Infect (2001) 1.20
Adolescent women can perform a point-of-care test for trichomoniasis as accurately as clinicians. Sex Transm Infect (2010) 1.16
Prevalence and predictors of sexually transmitted infection among newly incarcerated females. Sex Transm Dis (2008) 1.15
Investigation of metronidazole use during pregnancy and adverse birth outcomes. Antimicrob Agents Chemother (2012) 1.12
Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care. Sex Transm Dis (2012) 1.10
'Shelf life' of Trichomonas vaginalis. Int J STD AIDS (2003) 1.10
Evaluation of the OSOM Trichomonas rapid test versus wet preparation examination for detection of Trichomonas vaginalis vaginitis in specimens from women with a low prevalence of infection. J Clin Microbiol (2008) 1.10
Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010. Emerg Infect Dis (2012) 1.10
A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr (2010) 1.07
Condom effectiveness against non-viral sexually transmitted infections: a prospective study using electronic daily diaries. Sex Transm Infect (2012) 1.06
Prevalence of rectal Trichomonas vaginalis and Mycoplasma genitalium in male patients at the San Francisco STD clinic, 2005-2006. Sex Transm Dis (2008) 1.06
HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs. Sex Transm Dis (2008) 1.05
Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis (2001) 1.04
Use of nucleic acid amplification testing for diagnosis of anorectal sexually transmitted infections. J Clin Microbiol (2012) 1.03
Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis (2012) 1.02
A Trich-y question: should Trichomonas vaginalis infection be reportable? Sex Transm Dis (2013) 1.02
Screening for sexually transmitted diseases and hepatitis in 18-29-year-old men recently released from prison: feasibility and acceptability. Int J STD AIDS (2005) 1.02
Neglected parasitic infections in the United States: trichomoniasis. Am J Trop Med Hyg (2014) 1.02
Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis. Infect Dis Obstet Gynecol (2004) 1.01
Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women. Sex Transm Dis (2010) 1.00
Observation of probable persistent, undetected Trichomonas vaginalis infection among HIV-positive women. Clin Infect Dis (2010) 0.99
Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis: first-in-human studies. Clin Pharmacokinet (2014) 0.99
Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations. Sex Transm Dis (2011) 0.96
A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol (1998) 0.96
Genotoxicity profile of fexinidazole--a drug candidate in clinical development for human African trypanomiasis (sleeping sickness). Mutagenesis (2012) 0.95
Comparison of self-obtained penile-meatal swabs to urine for the detection of C. trachomatis, N. gonorrhoeae and T. vaginalis. Sex Transm Infect (2012) 0.95
Screening for Trichomonas vaginalis in high-risk adolescent females with a new transcription-mediated nucleic acid amplification test (NAAT): associations with ethnicity, symptoms, and prior and current STIs. J Pediatr Adolesc Gynecol (2010) 0.94
Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure. Sex Transm Dis (2011) 0.94
Treatment of sexually transmitted vaginosis/vaginitis. Rev Infect Dis (1990) 0.93
Prevalence and correlates of Trichomonas vaginalis among incarcerated persons assessed using a highly sensitive molecular assay. Sex Transm Dis (2010) 0.92
Influence of HIV-1 coinfection on effective management of abnormal vaginal discharge. Sex Transm Dis (2003) 0.92
Are maternal genitourinary infection and pre-eclampsia associated with ADHD in school-aged children? J Atten Disord (2010) 0.92
Determinants of HIV type 1 shedding from genital ulcers among men in South Africa. Clin Infect Dis (2010) 0.91
A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women. Sex Transm Dis (2013) 0.90
Does patient-delivered partner treatment improve disclosure for treatable sexually transmitted diseases? AIDS Patient Care STDS (2010) 0.90
Effect of trichomoniasis therapy on genital HIV viral burden among African women. Sex Transm Dis (2012) 0.89
The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women. Sex Transm Dis (2011) 0.89
Trichomonas adhere and phagocytose sperm cells: adhesion seems to be a prominent stage during interaction. Parasitol Res (2007) 0.89
Sexually transmitted infections and hepatitis in men with a history of incarceration. Sex Transm Dis (2011) 0.89
Metronidazole in breast milk. Obstet Gynecol (1981) 0.88
Brief counseling for reducing sexual risk and bacterial STIs among drug users--results from project RESPECT. Drug Alcohol Depend (2009) 0.88
Trichomoniasis in pregnancy and mental retardation in children. Ann Epidemiol (2009) 0.87
Trichomoniasis in men and HIV infection: data from 2 outpatient clinics at Lilongwe Central Hospital, Malawi. J Infect Dis (2004) 0.87
Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Am J Obstet Gynecol (2008) 0.87
The influence of ART on the treatment of Trichomonas vaginalis among HIV-infected women. Clin Infect Dis (2014) 1.10
Trichomonas vaginalis infection and prostate-specific antigen concentration: Insights into prostate involvement and prostate disease risk. Prostate (2019) 0.75
Insight into infection-mediated prostate damage: Contrasting patterns of C-reactive protein and prostate-specific antigen levels during infection. Prostate (2017) 0.75
Advances in the Understanding and Treatment of Male Urethritis. Clin Infect Dis (2015) 0.75